261 related articles for article (PubMed ID: 19141083)
1. Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies.
Hanes J; Zilka N; Bartkova M; Caletkova M; Dobrota D; Novak M
J Neurochem; 2009 Mar; 108(5):1167-76. PubMed ID: 19141083
[TBL] [Abstract][Full Text] [Related]
2. Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3zeta protein.
Sadik G; Tanaka T; Kato K; Yanagi K; Kudo T; Takeda M
Biochem Biophys Res Commun; 2009 May; 383(1):37-41. PubMed ID: 19324008
[TBL] [Abstract][Full Text] [Related]
3. Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies.
Umeda Y; Taniguchi S; Arima K; Piao YS; Takahashi H; Iwatsubo T; Mann D; Hasegawa M
Neurosci Lett; 2004 Apr; 359(3):151-4. PubMed ID: 15050686
[TBL] [Abstract][Full Text] [Related]
4. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes.
Jung HJ; Park SS; Mok JO; Lee TK; Park CS; Park SA
Exp Neurol; 2011 Apr; 228(2):232-41. PubMed ID: 21281635
[TBL] [Abstract][Full Text] [Related]
6. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
Cente M; Filipcik P; Pevalova M; Novak M
Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434
[TBL] [Abstract][Full Text] [Related]
7. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods.
Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055
[TBL] [Abstract][Full Text] [Related]
8. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
9. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
Zilka N; Korenova M; Novak M
Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
[TBL] [Abstract][Full Text] [Related]
10. Study of tauopathies by comparing Drosophila and human tau in Drosophila.
Chen X; Li Y; Huang J; Cao D; Yang G; Liu W; Lu H; Guo A
Cell Tissue Res; 2007 Jul; 329(1):169-78. PubMed ID: 17406902
[TBL] [Abstract][Full Text] [Related]
11. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
Sydow A; Mandelkow EM
Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454
[TBL] [Abstract][Full Text] [Related]
12. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
13. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
[TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-tocopherol on an animal model of tauopathies.
Nakashima H; Ishihara T; Yokota O; Terada S; Trojanowski JQ; Lee VM; Kuroda S
Free Radic Biol Med; 2004 Jul; 37(2):176-86. PubMed ID: 15203189
[TBL] [Abstract][Full Text] [Related]
15. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
Glatz DC; Rujescu D; Tang Y; Berendt FJ; Hartmann AM; Faltraco F; Rosenberg C; Hulette C; Jellinger K; Hampel H; Riederer P; Möller HJ; Andreadis A; Henkel K; Stamm S
J Neurochem; 2006 Feb; 96(3):635-44. PubMed ID: 16371011
[TBL] [Abstract][Full Text] [Related]
16. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.
Schindowski K; Belarbi K; Bretteville A; Ando K; Buée L
Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):92-100. PubMed ID: 18184373
[TBL] [Abstract][Full Text] [Related]
17. Expression of the embryonal isoform (0N/3R) of the microtubule-associated protein tau in the adult rat central nervous system.
Bullmann T; Härtig W; Holzer M; Arendt T
J Comp Neurol; 2010 Jul; 518(13):2538-53. PubMed ID: 20503426
[TBL] [Abstract][Full Text] [Related]
18. Dementia with Lewy bodies from the perspective of tauopathy.
Iseki E; Togo T; Suzuki K; Katsuse O; Marui W; de Silva R; Lees A; Yamamoto T; Kosaka K
Acta Neuropathol; 2003 Mar; 105(3):265-70. PubMed ID: 12557014
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.
Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS
Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765
[TBL] [Abstract][Full Text] [Related]
20. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]